Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up
R.I. Olivier(The Netherlands Cancer Institute), Laura J. van’t Veer(University of California, San Francisco), Marc J. van de Vijver(The Netherlands Cancer Institute), Thea M. Mooij(The Netherlands Cancer Institute), M.A.C. Lubsen(Amsterdam UMC Location University of Amsterdam), Matti A. Rookus(The Netherlands Cancer Institute), Marc van Beurden(Oncode Institute)
Cited by 133
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
|Journal of Clinical Oncology|2010|541